NOVARTIS PHARMA
Novartis Pharma is the Japanese subsidiary of Novartis Pharmaceuticals, a world-leading healthcare company based in Basel, Switzerland
NOVARTIS PHARMA
Industry:
Health Care Pharmaceutical
Founded:
1997-04-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Dainippon Sumitomo Pharma
Dainippon Sumitomo Pharma is a pharmaceutical company based in Japan.
The Family Doctor
The Family Doctor provides trustworthy and affordable healthcare for families.
Current Employees Featured
VAS Narasimhan CEO @ Novartis Pharma
CEO
2018-02-01
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-09 | H1.co | Novartis Pharma investment in Series C - H1.co | 23 M USD |
| 2021-09-01 | SomaLogic | Novartis Pharma investment in Post-IPO Equity - SomaLogic | 375 M USD |
| 2021-07-14 | Dopavision | Novartis Pharma investment in Series A - Dopavision | 12 M EUR |
| 2020-10-13 | Vineti | Novartis Pharma investment in Series C - Vineti | 33 M USD |
| 2020-09-28 | Koneksa Health | Novartis Pharma investment in Series B - Koneksa Health | 16 M USD |
| 2020-02-05 | Vineti | Novartis Pharma investment in Series C - Vineti | 35 M USD |
| 2012-11-13 | Peptidream | Novartis Pharma investment in Venture Round - Peptidream | 299 M JPY |
More informations about "Novartis Pharma"
Novartis Organizational Structure
Novartis organizational structure Last updated: March 2025 ECN Members. Kees Roks. Chief Audit Officer. Michelle Weese. Chief Corporate Affairs Officer. Rob Kowalski. Chief People & …See details»
Novartis announces new organizational structure to
Apr 4, 2022 Novartis will integrate the Pharmaceuticals and Oncology business units and create two separate commercial organizations with a stronger geographic focus—Innovative …See details»
Novartis - Wikipedia
Novartis was created in March 1996 and began operations on 20 December from the merger of Ciba-Geigy and Sandoz Laboratories, both Swiss companies. Ciba-Geigy was formed in 1970 by the merger of J. R. Geigy Ltd (founded in Basel in 1857) and CIBA (founded in Basel in 1859). See details»
Novartis
Mar 7, 2025 Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and …See details»
Novartis announces new organizational structure - World Pharma …
Apr 5, 2022 Novartis will integrate the Pharmaceuticals and Oncology business units and create two separate commercial organizations with a stronger geographic focus - Innovative …See details»
Novartis changes organizational structure to save at …
Apr 4, 2022 Novartis will integrate the Pharmaceuticals and Oncology business units and create two separate commercial organizations with a stronger geographic focus—Innovative Medicines US and Innovative Medicines …See details»
Org Chart Novartis - The Official Board
The organizational chart of Novartis displays its 543 main executives including Vasant Narasimhan, Harry Kirsch and Richard Saynor. Toggle navigation The Official ... Innovative Medicines @ Novartis Pharmaceutical... President @ …See details»
Company overview - Novartis
About Novartis. Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and …See details»
Novartis unveils major re-org | Pharma Manufacturing
Apr 4, 2022 Novartis has announced a new organizational structure and operating model, with an eye on innovation and growth — as well as targeted savings of at least $1 billion by 2024.. …See details»
Novartis Org Chart | PDF | Novartis | Business Process
Novartis-org-chart - Free download as PDF File (.pdf), Text File (.txt) or view presentation slides online. Novartis has a hierarchical organizational structure led by a Board of Directors and CEO. The CEO oversees several division heads …See details»
What is Next for Novartis? Restructuring on the Way
Jul 7, 2022 New operating structure and executive changes One key component for the strategy of Novartis CEO Vas Narasimhan is to implement a new organizational structure and …See details»
Amid restructuring, Novartis plots layoffs in …
Apr 9, 2024 Even as Novartis rolls ahead with a global restructuring campaign targeting thousands of job cuts, the Swiss drug giant has blueprinted several hundred layoffs in its development organizational unit.See details»
Novartis' global revamp to cost thousands of jobs for simpler ...
Apr 12, 2022 Novartis is undertaking a huge restructuring to simplify its organization, and some of its employees will feel the pain. The company will cut thousands of jobs worldwide as part of …See details»
Novartis Canada
At Novartis, we are reimagining medicine Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative …See details»
About - Novartis
Learn more about Novartis and explore our core therapeutic areas and technology platforms. Novartis is an innovative medicines company. Every day, we work to reimagine medicine to …See details»
The Culture And Leadership Code Of Novartis - Forbes
Jan 20, 2021 Novartis, the world's second largest pharmaceutical company based on prescription drug sales, is one such company. To learn more about how Novartis scales …See details»
Giovanni Caforio - Novartis
President, US Pharmaceuticals, BMS, US (2011-2013) Various managerial positions at BMS and Abbot Laboratories in the US, France, Italy, Portugal and Spain (1990-2011) Mandates …See details»
Novartis announces new organizational structure
Apr 5, 2022 Novartis will integrate the Pharmaceuticals and Oncology business units and create two separate commercial organizations with a stronger geographic focus - Innovative …See details»
Novartis Pharmaceuticals Corporation - amga.org
At Novartis, our purpose is to reimagine medicine to improve and extend people’s lives. We use innovative science and digital technologies to address some of society’s most challenging …See details»
Swiss pharma companies Roche and Novartis are ditching DEI
4 days ago Swiss pharma giants Roche (RHHBY-0.07%) and Novartis (NVS +1.22%) are the latest companies to adjust their diversity programs, reflecting broader shifts in how the …See details»